These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30426716)

  • 1. Red blood cell volume is not decreased in ESA-naive anemic chronic kidney disease patients.
    Lundby C; Ponte B; Lundby AK; Robach P; de Seigneux S
    Physiol Rep; 2018 Nov; 6(21):e13900. PubMed ID: 30426716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular volumes evaluated by a carbon monoxide rebreathing method in patients undergoing chronic hemodialysis.
    Bomholt T; Larsson S; Rix M; Rytter S; Feldt-Rasmussen B; Hornum M; Lundby C
    Hemodial Int; 2020 Apr; 24(2):252-260. PubMed ID: 32052563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True Anemia-Red Blood Cell Volume Deficit-in Heart Failure: A Systematic Review.
    Montero D; Lundby C; Ruschitzka F; Flammer AJ
    Circ Heart Fail; 2017 May; 10(5):. PubMed ID: 28455293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Novel Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (GSK1278863) for Anemia in CKD: A 28-Day, Phase 2A Randomized Trial.
    Brigandi RA; Johnson B; Oei C; Westerman M; Olbina G; de Zoysa J; Roger SD; Sahay M; Cross N; McMahon L; Guptha V; Smolyarchuk EA; Singh N; Russ SF; Kumar S;
    Am J Kidney Dis; 2016 Jun; 67(6):861-71. PubMed ID: 26827289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial stiffness is strongly and negatively associated with the total volume of red blood cells.
    Montero D; Diaz-Cañestro C; Keiser S; Lundby C
    Int J Cardiol; 2016 Oct; 221():77-80. PubMed ID: 27400301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Fluorescent Clinical Method to Rapidly Quantify Plasma Volume.
    Molitoris BA; George AG; Murray PT; Meier D; Reilly ES; Barreto E; Sandoval RM; Rizk DV; Shaw AD; Peacock WF
    Cardiorenal Med; 2019; 9(3):168-179. PubMed ID: 30844821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical impact of the ERBP Working Group 2010 Recommendations for the anemia management in chronic kidney disease not on dialysis: ACERCA study.
    Martínez-Castelao A; Cases A; Carballada AT; Iranzo JT; Bronsoms J; Vallès-Prats M; Monserrat DT; Jimenez EM;
    Nefrologia; 2015; 35(2):179-88. PubMed ID: 26300512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietic Response to Anaemia of Dialysis Naïve Patients with Chronic Kidney Disease in Zaria, North-West Nigeria.
    Dogara LG; Hassan A; Awwalu S; Okpetu L; Waziri AD; Babadoko AA; Bosan IB; Muktar HM
    Niger J Clin Pract; 2018 Feb; 21(2):189-194. PubMed ID: 29465053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal anemia and hydration status in non-dialysis chronic kidney disease: Is there a link?
    Hildegard Stancu S; Stanciu A; Lipan M; Capusa C
    J Med Life; 2018; 11(4):293-298. PubMed ID: 30894885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Risk factors for anemia in the early stages of chronic kidney disease].
    Milovanov YS; Kozlovskaya LV; Milovanova LY; Markina MM; Kozlov VV; Taranova MV; Fomin VV
    Ter Arkh; 2017; 89(6):41-47. PubMed ID: 28745688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C.E.R.A. administered once monthly corrects and maintains stable hemoglobin levels in chronic kidney disease patients not on dialysis: the observational study MICENAS II.
    Martínez-Castelao A; Cases A; Coll E; Bonal J; Galceran JM; Fort J; Moreso F; Torregrosa V; Guirado L; Ruiz P;
    Nefrologia; 2015; 35(1):80-6. PubMed ID: 25349927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Placebo-Controlled, Randomized Trial of Enarodustat in Patients with Chronic Kidney Disease Followed by Long-Term Trial.
    Akizawa T; Nangaku M; Yamaguchi T; Arai M; Koretomo R; Matsui A; Hirakata H
    Am J Nephrol; 2019; 49(2):165-174. PubMed ID: 30699415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of chronic kidney disease and anemia on health-related quality of life and work productivity: analysis of multinational real-world data.
    van Haalen H; Jackson J; Spinowitz B; Milligan G; Moon R
    BMC Nephrol; 2020 Mar; 21(1):88. PubMed ID: 32143582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of erythropoiesis-stimulating agents on healthcare utilization, costs, and outcomes in chronic kidney disease.
    Maddux FW; Shetty S; del Aguila MA; Nelson MA; Murray BM
    Ann Pharmacother; 2007 Nov; 41(11):1761-9. PubMed ID: 17895328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: the Handling Erythropoietin Resistance With Oxpentifylline (HERO) trial.
    Johnson DW; Pascoe EM; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; McDonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM;
    Am J Kidney Dis; 2015 Jan; 65(1):49-57. PubMed ID: 25115616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral roxadustat three times weekly in ESA-naïve and ESA-converted patients with anemia of chronic kidney disease on hemodialysis: Results from two phase 3 studies.
    Akizawa T; Ueno M; Shiga T; Reusch M
    Ther Apher Dial; 2020 Dec; 24(6):628-641. PubMed ID: 31891449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of achieved hemoglobin level on renal outcome in non-dialysis chronic kidney disease (CKD) patients receiving epoetin beta pegol: MIRcerA CLinical Evidence on Renal Survival in CKD patients with renal anemia (MIRACLE-CKD Study).
    Hayashi T; Uemura Y; Kumagai M; Kimpara M; Kanno H; Ohashi Y;
    Clin Exp Nephrol; 2019 Mar; 23(3):349-361. PubMed ID: 30291472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non-Dialysis-Dependent CKD: Pooled Results of Three Randomized Clinical Trials.
    Provenzano R; Szczech L; Leong R; Saikali KG; Zhong M; Lee TT; Little DJ; Houser MT; Frison L; Houghton J; Neff TB
    Clin J Am Soc Nephrol; 2021 Aug; 16(8):1190-1200. PubMed ID: 34362786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.